NewsPronto

 
The Times


.

ACN Newswire

Read more press releases from ACN Newswire here

Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform

  • Written by ACN Newswire

image

- Nobel Prize nominee Daryl Thompson to lead research, conducted by subsidiary Global BioLife Inc., supported by Charles River Laboratories- Six month target for validating lab data, twelve month target for completion of platform

SINGAPORE, May 22, 2017 - (ACN Newswire) - Singapore eDevelopment Ltd ("SeD"), through subsidiary Global BioLife Inc....

Read more: Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform